We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
Price data last checked 49 day(s) ago - refreshing...
Price History & Forecast
Last 42 days • 42 data points (No recent data available)
Price Distribution
Price distribution over 42 days • 1 price levels
Price Analysis
Most common price: £495 (42 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 42 days
Product Specifications
- Format
- paperback
- ASIN
- B0BBJRFD27
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 16 August 2022
- Listed Since
- 26 August 2022
Similar Products You Might Like
97% match
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China
£495.00
20 Jan 2026
97% match
The 2023-2028 Outlook for Cancer Screenings in China
£495.00
16 Dec 2025
97% match
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
£495.00
20 Mar 2026
97% match
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
£495.00
07 Jan 2026
97% match
The 2023-2028 Outlook for Genomics in Cancer Care in China
£495.00
04 Feb 2026
97% match
The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in China
£495.00
25 Jan 2026
97% match
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China
£495.00
10 Mar 2026
97% match
The 2023-2028 Outlook for Drug Delivery Products in China
£495.00
14 Jan 2026
97% match
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China
£495.00
12 Jan 2026
97% match
The 2023-2028 Outlook for OTC Drugs in China
£495.00
07 Mar 2026
97% match
Endometrial Cancer Treatments in China 2023-2028 Outlook
£495.00
04 Apr 2026
97% match
The 2023-2028 Outlook for Cervical Cancer Treatments in China
£495.00
25 Jan 2026
96% match
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in China
£495.00
08 Jan 2026
96% match
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in China
£495.00
12 Jan 2026
96% match
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China
£495.00
11 Jan 2026
96% match
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China
£495.00
12 Jan 2026
96% match
The 2023-2028 Outlook for Lymphoma Treatments in China
£495.00
23 Jan 2026
96% match
The 2023-2028 Outlook for Anti-Malarial Drugs in China
£495.00
12 Jan 2026
96% match
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China
£495.00
09 Jan 2026
96% match
The 2023-2028 Outlook for Erythropoietin Drugs in China
£495.00
01 Feb 2026
96% match
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
£495.00
12 Jan 2026
96% match
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China
£495.00
26 Jan 2026
96% match
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
£495.00
19 Apr 2026
96% match
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
£495.00
25 Jan 2026